Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes

Signal Transduct Target Ther. 2022 Aug 13;7(1):285. doi: 10.1038/s41392-022-01137-1.

Yang Liu^#^{1

2}, Jianying Liu^#^{2

3}, Jing Zou^#¹, Birte Kalveram^{1

3}, Rafael R G Machado³, Ping Ren⁴, Sina Türeli⁵, Derek J Smith⁵, Scott C Weaver³, Xuping Xie⁶, Pei-Yong Shi^{7

8

9}

¹ Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
² Institute of Infectious Diseases, Shenzhen Bay Laboratory, Shenzhen, China.
³ Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
⁴ Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
⁵ Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK.
⁶ Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. xuxie@UTMB.edu.
⁷ Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.
⁸ Sealy Institute for Drug Discovery, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.
⁹ Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.

^# Contributed equally.

No abstract available

Publication types